TipRanks
Advertisement
Advertisement

DMRA Stock Latest News

Damora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing
Company AnnouncementsDamora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing
13d ago
DMRA
Damora Therapeutics price target raised, named a Best Idea at Guggenheim
PremiumThe Fly
Damora Therapeutics price target raised, named a Best Idea at Guggenheim
18d ago
DMRA
INCY
Analyst Reiterates Buy on Damora, Citing mutCALR Leadership and Strong Pipeline with Unchanged $45 Price Target
PremiumRatings
Analyst Reiterates Buy on Damora, Citing mutCALR Leadership and Strong Pipeline with Unchanged $45 Price Target
25d ago
DMRA
Damora Maintained at Buy as Analyst Cites Strong mutCALR Pipeline, Robust Cash Runway and Reaffirms $45 Price Target
PremiumRatings
Damora Maintained at Buy as Analyst Cites Strong mutCALR Pipeline, Robust Cash Runway and Reaffirms $45 Price Target
2M ago
DMRA
Analyst Reiterates Buy on Damora Therapeutics, Maintains $45 Price Target on Differentiated Clinical Strategy
PremiumRatings
Analyst Reiterates Buy on Damora Therapeutics, Maintains $45 Price Target on Differentiated Clinical Strategy
2M ago
DMRA
Analyst Initiates Buy on Damora Therapeutics Citing Strong mCALR Pipeline, Accelerated CLARITY-101 Readouts, and Funding Runway Into 2029
PremiumRatingsAnalyst Initiates Buy on Damora Therapeutics Citing Strong mCALR Pipeline, Accelerated CLARITY-101 Readouts, and Funding Runway Into 2029
2M ago
DMRA
Sam Slutsky Reiterates Buy Rating on Damora Therapeutics, Maintains $45 Price Target on Promising DMR-001 Profile
Premium
Ratings
Sam Slutsky Reiterates Buy Rating on Damora Therapeutics, Maintains $45 Price Target on Promising DMR-001 Profile
2M ago
DMRA
Damora Therapeutics price target raised to $40 from $35 at Wedbush
Premium
The Fly
Damora Therapeutics price target raised to $40 from $35 at Wedbush
2M ago
DMRA
INCY
Damora Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Damora Therapeutics initiated with a Buy at Jefferies
3M ago
DMRA
INCY
Damora Therapeutics: Buy Rating Reaffirmed on Differentiated ET/MF Candidate and $50 Price Target
PremiumRatings
Damora Therapeutics: Buy Rating Reaffirmed on Differentiated ET/MF Candidate and $50 Price Target
3M ago
DMRA
Damora Therapeutics Completes Cayman Islands Redomestication
PremiumCompany Announcements
Damora Therapeutics Completes Cayman Islands Redomestication
3M ago
8K
DMRA
Damora Therapeutics completes redomestication to the Cayman Islands
PremiumThe Fly
Damora Therapeutics completes redomestication to the Cayman Islands
3M ago
DMRA
Damora Therapeutics Announces Results of 2026 Annual Meeting
PremiumCompany AnnouncementsDamora Therapeutics Announces Results of 2026 Annual Meeting
4M ago
8K
DMRA
Damora Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Damora Therapeutics initiated with a Buy at H.C. Wainwright
4M ago
DMRA
Wedbush bullish on Damora Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Damora Therapeutics, initiates with an Outperform
5M ago
DMRA
INCY
Damora Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Damora Therapeutics initiated with an Outperform at Wedbush
5M ago
DMRA
Damora Therapeutics Announces CFO Transition to Internal Leader
PremiumCompany Announcements
Damora Therapeutics Announces CFO Transition to Internal Leader
5M ago
8K
DMRA
Damora Therapeutics initiated with an Outperform at RBC Capital
PremiumThe Fly
Damora Therapeutics initiated with an Outperform at RBC Capital
6M ago
DMRA
Damora Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
Damora Therapeutics initiated with an Outperform at Evercore ISI
7M ago
DMRA
Damora Therapeutics Announces Major Leadership and Board Overhaul
PremiumCompany AnnouncementsDamora Therapeutics Announces Major Leadership and Board Overhaul
7M ago
8K
DMRA
Damora names Peter Harwin chairman, appoints Spyre Therapeutics CEO to board
Premium
The Fly
Damora names Peter Harwin chairman, appoints Spyre Therapeutics CEO to board
7M ago
DMRA
SYRE
Damora Therapeutics appoints Jennifer Jarrett as CEO
Premium
The Fly
Damora Therapeutics appoints Jennifer Jarrett as CEO
7M ago
DMRA
RCUS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >